| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |